Avita Medical (AVMXY) 1.2000 $AVMXY Avita Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Avita Medical (AVMXY) 1.2000 $AVMXY

Avita Medical Announces Issuance of a New U.S. Patent for ReCell(R)
Marketwired - Wed May 13, 5:01AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,029,140. The patent is directed to methods of making and using an epithelial cell suspension, part of the Company's novel autologous skin regeneration therapy platform (ReCell(R)).
AVH: 11.33 (-0.39)

Avita Medical Granted CE Mark for Expanded ReCell(TM)
Marketwired - Mon Apr 27, 4:30AM CDT
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that it has received a CE Mark for a new ReCell device for the treatment of burns. This enhanced ReCell product offers treatment of up to a 1,920cm2 surface area; a 6-fold greater coverage than previously possible from the first generation product. The original ReCell device, covering 320cm2, allowed clinicians to treat only approximately 1.5% of an adult's total body surface area (TBSA). With the new device, ReCell is better aligned to meet grafting requirements of burn victims.
AVH: 11.33 (-0.39)

Avita Hosts International Skin Regeneration Symposium Attended by Leading Clinicians
Marketwired - Thu Apr 23, 4:30AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds, scars, and skin defects, today provided a summary of its Skin Regeneration Symposium which was held on April 14th - 15th at Cambridge University. The forum, which was attended by more than 80 clinicians from around the world, featured keynote speakers; presentations and panel discussions all focused on using regenerative medicine to treat burns, wound care, trauma, aesthetic revision and plastics reconstruction. A key outcome from the symposium was the conclusion that a novel epithelial suspension used to regenerate skin for patients suffering from burns and chronic wounds can be a vital part of a surgeon's toolkit, and results can be further optimised when ReCell is used with other standard medical devices.
AVH: 11.33 (-0.39)

100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 1.37 (+0.06), GBSNU: 16.10 (-0.09), MZOR: 11.85 (+0.16), FEIC: 78.14 (+0.79), ZLTQ: 28.92 (+0.08), IART: 66.00 (+0.04), BVX: 2.70 (-0.07)

Avita Medical Appoints Adam Kelliher as Chief Executive Officer
Marketwired - Tue Apr 14, 4:30AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced the appointment of Mr. Adam Kelliher as Chief Executive Officer. Tim Rooney, who has been serving as Interim Chief Executive Officer, will resume his role as the Company's Chief Financial Officer and Chief Operating Officer.
AVH: 11.33 (-0.39)

Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell(R) for the Treatment of Burns
Marketwired - Wed Jan 28, 4:30AM CST
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company's Pivotal Phase III burn trial for ReCell(R).
AVH: 11.33 (-0.39)

UPDATE - Avita Medical Provides NICE Guidance Recommendation Update
Marketwired - Wed Nov 12, 4:04PM CST
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced the United Kingdom's National Institute for Health and Care Excellence (NICE) has issued guidance around the use of ReCell(R) Spray-on Skin(R) for the treatment of skin loss, scarring and depigmentation after a burn injury. While NICE commented that ReCell demonstrates potential to improve healing of acute burns, more evidence is required before a formal recommendation can be granted.
AVH: 11.33 (-0.39)

Avita Medical Provides NICE Guidance Recommendation Update
Marketwired - Wed Nov 12, 12:10PM CST
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced the United Kingdom's National Institute for Health and Care Excellence (NICE) has issued guidance around the use of ReCell(R) Spray-on Skin(R) for the treatment of skin loss, scarring and depigmentation after a burn injury. While NICE commented that ReCell demonstrates potential to improve healing of acute burns, more evidence is required before a formal recommendation can be granted. The Company is continuing collaboration with the Medical Technologies Evaluation Programme at NICE toward further development of the evidence base.
AVH: 11.33 (-0.39)

Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive
Marketwired - Tue Nov 11, 4:30AM CST
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that it has received an Australian R&D Tax Incentive payment of $1.4M for the financial year ending 30 June 2014.
AVH: 11.33 (-0.39)

Avita Medical Secures US FDA Approval to Modify ReCell(R) Clinical Burns Trial
Marketwire - Tue Sep 16, 11:25AM CDT
Highlights
AVH: 11.33 (-0.39)

Scar Treatment Market to 2018: Gels, Creams, Oils and Sprays & Invasive Surgical Treatment, Laser Treatment, Elastic Wraps and Gel Sheets
M2 - Wed Jul 16, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4tlhl/global_scar) has announced the addition of the "Global Scar Treatment Market 2014-2018" report to their offering. Scar treatment products are applied on a scar to treat, heal, and conceal the scar. Products such as gels, creams, oils, and sprays are available as OTC products or are prescribed to treat scars. They are an alternative to invasive surgical treatment, laser treatment, elastic wraps, and gel sheets. Scar treatment application products are easy to use and cost-effective in comparison with invasive treatments. The Global Scar Treatment market can be divided into three segments: Burn Scars, Post-surgical Scars Other than Burn Scars, and Others. Burn scars, also known as hypertrophic scars, stay within the area of the original burn. The treatment of post-surgical scars varies with the degree of scarring. The treatment removes the scars caused by minor surgeries such as appendectomy or Caesarean section scars. Some scars can be hypersensitive and decrease ability to move. The Others segment includes scar treatment for aesthetic reasons such as the reduction in the appearance of acne scars. The Global Scar Treatment market is driven by many factors, one of which is an increase in appearance-consciousness among consumers. Scars leave an undesirable mark on the skin, which has a profound impact on the physical and mental well-being of a person. There has been an increase in the desire to maintain flawless skin, which is leading to an increase in the number of personal care and pharmaceutical scar treatment products. The report states that the risk of side effects is one of the major challenges. Scar treatment products may contain harmful chemicals that could cause side effects. Therefore, consumers are more concerned about the ingredients in these products. Some vendors are unable to meet the expectations of customers when it comes to safety standards. Key Vendors - CCA Industries Inc. - Merz Pharmaceuticals GmbH & Co. KGaA - Oculus Innovative Sciences Inc. - Pacific World Corp. Other Prominent Vendors - Avita Medical Ltd. - Enaltus LLC - Quantum Inc. - Revitol Corp. - Scarguard Labs LLC - Valeant Pharmaceuticals International Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c4...lobal_scar
CAW: 3.11 (+0.01), OCLS: 0.86 (+0.03), VRX.TO: 270.02 (+2.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 29

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 5

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 14

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 129

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 91

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 51

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 157

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 265

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 134

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading

Top 5 Most Recently Viewed Articles

Jøtul Group's Financial Challenges and Strategic Response

Updated Category News Views 138

Understanding the Jøtul Group's Financial Landscape The Jøtul Group is a major player in the fireplace market, known for its exceptional range of products that cater to various consumer preferences. Founded in 1853, this company proudly represents some of Europe's most reputable brands, including Jøtul, Scan, and Ravelli. Each brand encapsulates a unique design...

Continue Reading
Capri Holdings Limited Faces Legal Scrutiny: What You Need to Know

Updated Category News Views 425

Capri Holdings Limited Under Investigation Capri Holdings Limited, known for its involvement in the luxury fashion sector, has recently come under the spotlight due to an ongoing investigation. This investigation is being led by the Law Offices of Howard G. Smith on behalf of the investors of the company. The core of the inquiry centers around potential violations of...

Continue Reading
eBay's Year-End Performance and 2025 Outlook Highlights

Updated Category News Views 1606

eBay Inc. Financial Performance Overview eBay Inc. has showcased remarkable financial growth in its latest performance report. The company announced substantial revenue figures and gross merchandise volume (GMV) for the last quarter and the full year, reinforcing its position as a leading global commerce platform. Key Financial Highlights of Q4 eBay's revenue reached an...

Continue Reading
Join Us for a Free Webinar on Stepfamily Support Strategies

Updated Category News Views 183

Understanding Stepfamily Dynamics Navigating the complexities of blended families can be challenging, and that is exactly why this free webinar, titled From Conflict to Connection: Navigating Stepfamily Dynamics, offers unparalleled insights for parents and stepparents alike. The event is set to feature expert panelists who specialize in co-parenting and stepfamily...

Continue Reading
Lamb Weston Faces Sharp Decline Amid Nasdaq Rally in Stocks

Updated Category News Views 143

Nasdaq Composite Shows Robust Gains The U.S. stock market experienced a positive trajectory as the Nasdaq Composite surged over 1% on a recent trading day. Investors found motivation in the optimistic outlook surrounding technology shares, which rose by 1.6%. Dow and S&P 500 Performance The Dow Jones Industrial Average reflected a modest uptick of 0.55%, reaching an...

Continue Reading